34 reports

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

The MicroPEARLS spray freezing technology allows for the timely release of these two key nutrients throughout an animal' s gastrointestinal (GI) tract.

  • Mineral Supplement
  • World
  • Market Size
  • Ajinomoto Co., Inc.
  • Cargill Inc.
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

By the year 2040, ## adult in ## will have diabetes.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

It is used to enhance rumen and gastrointestinal tract function.

  • Cattle
  • Mineral Supplement
  • World
  • Market Size
  • Nutreco N.V.
  • Pipeline analysis

Sotagliflozin is a small molecule and exhibits its mechanism by inhibiting SGLT-##, which helps absorb glucose and galactose in the gastrointestinal (GI) tract, and SGLT-##, which helps in glucose reabsorption by the kidney.

  • Type 1 Diabetes
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

The alleviation of gastrointestinal morbidity and other diseases in livestock, such as swine dysentery and acidosis in ruminants, is another advantage of feed ingredients enzymes.

  • Mineral Supplement
  • Colombia
  • South America
  • Market Size
  • Alltech Inc.

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

MARKET SEGMENTATION ##.

  • Mineral Supplement
  • Argentina
  • Croda International Plc
  • Danone SA
  • General Mills, Inc.

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.

  • Endocrine Disease
  • Mineral Supplement
  • United States
  • World
  • Product Initiative
  • SYNTHETIC PEPTIDE TO AGONIZE NK1 FOR TYPE 1 DIABETES - DRUG PROFILE
  • COMPUGEN LTD

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • Chronic Disease
  • Mineral Supplement
  • Type 1 Diabetes
  • United States
  • Company

NIHS' research categories comprise brain health, molecular nutrition, system science, cell biology, mitochondrial function, omics, informatics, cognitive health and ageing, metabolic health, and gastrointestinal health.

  • Type 1 Diabetes
  • United States
  • Company
  • Product Initiative
  • ViaCyte, Inc.

BioChaperone Glargine GLP-##, ##-in-## combinations of basal insulin glargine and GLP-## receptor agonists: BioChaperone Glargine Dulaglutide and BioChaperone Glargine Liraglutide.

  • Healthcare
  • Type 1 Diabetes
  • France
  • Company
  • Adocia

Participants were allocated ##:##:##:## to receive daily infusions of teplizumab (full dose for ## days, ##/ ## dose for ## days, or full dose for six days) or placebo at baseline and at six months.

  • Therapy
  • Type 1 Diabetes
  • United States
  • World
  • Product Initiative

Inflammatory bowel disease (IBD) is one of the most functional gastrointestinal disorders, caused due to abnormal immune response.

  • Immunochemistry Test
  • Type 1 Diabetes
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • 1.1 MARKET DEFINITION

Such drugs with sensorial effects are mainly developed in the cough, cold & allergy and gastrointestinal categories.

  • Mineral Supplement
  • OTC
  • Spain
  • Forecast
  • Sanofi S.A.
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY REGIMMUNE CORPORATION, H2 2016
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY CARLINA TECHNOLOGIES SAS, H2 2016

It discovers, develops and commercializes medicines for gastrointestinal disorders.

  • Biotech
  • Mineral Supplement
  • Type 1 Diabetes
  • Company
  • Product Initiative
  • Type 1 Diabetes
  • Telotristatetiprate (LX1032)

SGLT## is a transporter responsible for glucose and galactose absorption in the gastrointestinal tract.

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Mineral Supplement
  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative

The molecules developed by companies in Phase III, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Shenogen Pharma Group